Related references
Note: Only part of the references are listed.Effect of Protein Kinase C beta Inhibition on Renal Hemodynamic Function and Urinary Biomarkers in Humans With Type 1 Diabetes: A Pilot Study
David Z. I. Cherney et al.
DIABETES CARE (2009)
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
G. M. Magee et al.
DIABETOLOGIA (2009)
The effect of cyclooxygenase-2 inhibition on renal. Hemodynamic function in humans with type 1 diabetes
David Z. I. Cherney et al.
DIABETES (2008)
Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes
S. Cuzzocrea et al.
KIDNEY INTERNATIONAL (2007)
Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes
Etienne B. Sochett et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers - Randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatation
S Verma et al.
CIRCULATION (2001)
Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
R Komers et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
R Korners et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects
DR Meeking et al.
DIABETES CARE (2000)
Share Paper
